We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ENGN market cap is 567.43M. The company's latest EPS is CAD -2.2927 and P/E is -5.77.
Quarter End | Jul 2023 |
---|---|
CAD ($) | |
Total Revenue | 0 |
Operating Income | -72.1M |
Net Income | -72.49M |
Year End 31 October 2023 | 2023 |
---|---|
CAD ($) | |
Total Revenue | 0 |
Operating Income | -26.06M |
Net Income | -99.92M |
Quarter End | Jul 2023 |
---|---|
CAD ($) | |
Total Assets | 7k |
Total Liabilities | 72.49M |
Total Equity | -72.48M |
Year End 31 October 2023 | 2023 |
---|---|
CAD ($) | |
Total Assets | 86.96M |
Total Liabilities | 14.47M |
Total Equity | 72.49M |
Market Cap | 567.43M |
Price to Earnings Ratio | -5.77 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 7.07 |
Price to Book Ratio | 7.95 |
Dividend Yield | - |
Shares Outstanding | 43.58M |
Average Volume (1 week) | 5.73k |
Average Volume (1 Month) | 93.11k |
52 Week Change | -23.37% |
52 Week High | 43.00 |
52 Week Low | 6.69 |
Spread (Intraday) | 0.73 (5.51%) |
Company Name | enGene Holdings Inc |
Address |
suite 2600, three bentall centre, 595 burrard street vancouver, british columbia V7X 1L3 |
Website | https:// |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions